Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1

Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1

Introduction: Primary hyperoxaluria type 1 (PH1) is a rare genetic disease caused by hepatic overproduction of oxalate, leading to kidney stones, nephrocalcinosis, kidney failure, and systemic oxalosis. In the 6-month double-blind period (DBP) of ILLUMINATE-A, a phase 3, randomized, placebo-controll...

Full description

Bibliographic Details
Main Authors:	Sally A. Hulton, Jaap W. Groothoff, Yaacov Frishberg, Michael J. Koren, J. Scott Overcash, Anne-Laure Sellier-Leclerc, Hadas Shasha-Lavsky, Jeffrey M. Saland, Wesley Hayes, Daniella Magen, Shabbir H. Moochhala, Martin Coenen, Eva Simkova, Sander F. Garrelfs, David J. Sas, Kristin A. Meliambro, Taylor Ngo, Marianne T. Sweetser, Bahru A. Habtemariam, John M. Gansner, Tracy L. McGregor, John C. Lieske
Format:	Article
Language:	English
Published:	Elsevier 2022-03-01
Series:	Kidney International Reports
Subjects:	lumasiran nephrocalcinosis phase 3 clinical trial primary hyperoxaluria type 1 RNA interference urinary oxalate
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024921015916

Similar Items

Lumasiran in the Management of Patients with Primary Hyperoxaluria Type 1: From Bench to Bedside
by: D'Ambrosio V, et al.
Published: (2022-06-01)

Case Report: Sustained Efficacy of Lumasiran at 18 Months in Primary Hyperoxaluria Type 1
by: Benedetta Chiodini, et al.
Published: (2022-01-01)

Lumasiran for primary hyperoxaluria type 1: What we have learned?
by: Xuan Gang, et al.
Published: (2023-01-01)

Case Report: effect of lumasiran treatment in a late preterm baby with antenatal diagnosis of primary hyperoxaluria type 1
by: Francesca Taroni, et al.
Published: (2024-01-01)

Primary hyperoxaluria: a case series
by: Jawad Iqbal Rather, et al.
Published: (2023-10-01)

A Case Report of Kidney-Only Transplantation in Primary Hyperoxaluria Type 1: A Novel Approach with the Use of Nedosiran
by: Matthew C. Breeggemann, et al.
Published: (2023-07-01)

Lanthanum carbonate to control plasma and urinary oxalate level in type 1 primary hyperoxaluria?
by: Agnieszka Pozdzik, et al.
Published: (2021-07-01)

Primary Hyperoxaluria Type 1: The First Patient Treated with Lumasiran in Portugal
by: Madalena Almeida Borges, et al.
Published: (2023-06-01)

Generation of a mouse model of Primary Hyperoxaluria Type 1 via CRISPR/Cas9 mediated gene editing
by: Kimberly A Coughlan, et al.
Published: (2019-06-01)

Primary hiperoxaluria diagnosed after kidney transplantation: report of 2 cases and literature review
by: John Fredy Nieto Rios, et al.

Unusual cause of renal failure in infancy: Primary hyperoxaluria
by: Kanchan Channawar, et al.
Published: (2015-01-01)

Hyperoxaluria; a risk factor or a consequence of recurrent pyelonephritis?
by: Natalia Stepanova
Published: (2021-10-01)

Frequency and impact of enteric hyperoxaluria in pediatric short bowel syndrome: a retrospective single centre study
by: Jan Thomas Schaefer, et al.
Published: (2023-07-01)

Characterising a healthy adult with a rare HAO1 knockout to support a therapeutic strategy for primary hyperoxaluria
by: Tracy L McGregor, et al.
Published: (2020-03-01)

Primary hyperoxaluria as a cause of renal failure in an infant
by: Hossein Emad Momtaz, et al.
Published: (2018-07-01)

Natural History of Clinical, Laboratory, and Echocardiographic Parameters of a Primary Hyperoxaluria Cohort on Long Term Hemodialysis
by: David J. Sas, et al.
Published: (2021-04-01)

Acute oxalate nephropathy following kidney transplantation: Report of three cases
by: Diana Taheri, et al.
Published: (2015-01-01)

Primary Hyperoxaluria Type 1 with Thrombophilia in Pregnancy: A Case Report
by: Asma Hasan, et al.
Published: (2018-10-01)

Long-term outcome after combined or sequential liver and kidney transplantation in children with infantile and juvenile primary hyperoxaluria type 1
by: Sebastian Loos, et al.
Published: (2023-03-01)

Catabolism of Hydroxyproline in Vertebrates: Physiology, Evolution, Genetic Diseases and New siRNA Approach for Treatment
by: Ruth Belostotsky, et al.
Published: (2022-01-01)

Molecular analysis of the AGXT gene in Syrian patients suspected with primary hyperoxaluria type 1
by: Hossam Murad, et al.
Published: (2021-06-01)

Liver-Kidney Transplantation in Primary Hyperoxaluria Type-1: Case Report and Literature Review
by: D Siegal, et al.
Published: (2011-07-01)

The Struggling Odyssey of Infantile Primary Hyperoxaluria
by: Adrien Guillaume, et al.
Published: (2021-04-01)

Protective Effects of Quercetin on Oxidative Stress-Induced Tubular Epithelial Damage in the Experimental Rat Hyperoxaluria Model
by: Ahmet Guzel, et al.
Published: (2021-06-01)

Reduced Electroretinogram Responses in Morphologically Normal Retina in Patients with Primary Hyperoxaluria Type 1
by: Efrat Naaman, MD, et al.
Published: (2023-06-01)

The Long Pentraxin PTX3 Is an Endogenous Inhibitor of Hyperoxaluria-Related Nephrocalcinosis and Chronic Kidney Disease
by: Julian A. Marschner, et al.
Published: (2018-09-01)

HYPEROXALURIA AND BIOMARKERS OF MUCOSAL IMMUNITY IN PATIENTS WITH RECURRENT PYELONEPHRITIS
by: M. Kolesnyk, et al.
Published: (2014-06-01)

Palmar papules as a manifestation of cutaneous oxalosis in primary hyperoxaluria: A case report and review of the literature
by: Hadi Alabdullah, et al.
Published: (2024-01-01)

Citrus Bioflavonoids Ameliorate Hyperoxaluria Induced Renal Injury and Calcium Oxalate Crystal Deposition in Wistar Rats
by: Sridharan Badrinathan, et al.
Published: (2015-09-01)

Urinary monocyte chemoattractant protein 1 associated with calcium oxalate crystallization in patients with primary hyperoxaluria
by: Xiangling Wang, et al.
Published: (2020-04-01)

Efficacy of Hydroxy-L-proline (HYP) analogs in the treatment of primary hyperoxaluria in Drosophila Melanogaster
by: Huan Yang, et al.
Published: (2018-07-01)

Small Molecule-Based Enzyme Inhibitors in the Treatment of Primary Hyperoxalurias
by: Maria Dolores Moya-Garzon, et al.
Published: (2021-01-01)

Limited Treatment Options in Primary Hyperoxaluria with Renal Failure
by: Kyle Geiger, et al.
Published: (2020-10-01)

An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluria
by: David Lubkowicz, et al.
Published: (2022-03-01)

Plasma Oxalate as a Predictor of Kidney Function Decline in a Primary Hyperoxaluria Cohort
by: Ronak Jagdeep Shah, et al.
Published: (2020-05-01)

Qualitative assessment of the patient experience of primary hyperoxaluria type 1: an observational study
by: David Danese, et al.
Published: (2023-10-01)

In vivo CRISPR-Cas9 inhibition of hepatic LDH as treatment of primary hyperoxaluria
by: Rebeca Martinez-Turrillas, et al.
Published: (2022-06-01)

Mutation Hot Spot Region in the HOGA1 Gene Associated with Primary Hyperoxaluria Type 3 in the Chinese Population
by: Wenying Wang, et al.
Published: (2019-08-01)

The type Ic morphology of urinary calculi: an alert to primary hyperoxaluria? Experience with 43 Moroccan children
by: Meiouet, Faïza, et al.
Published: (2022-03-01)

Identification of compound heterozygous patients with primary hyperoxaluria type 1: clinical evaluations and in silico investigations
by: Houda Kanoun, et al.
Published: (2017-10-01)